Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 48 ($0.62) and last traded at GBX 49.01 ($0.63), with a volume of 10588 shares trading hands. The stock had previously closed at GBX 50.50 ($0.65).
Arecor Therapeutics Stock Performance
The firm has a market cap of £18.13 million, a price-to-earnings ratio of -1.70 and a beta of -0.18. The company has a quick ratio of 6.24, a current ratio of 1.37 and a debt-to-equity ratio of 5.51. The stock has a fifty day moving average price of GBX 55.78 and a 200-day moving average price of GBX 67.39.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Articles
- Five stocks we like better than Arecor Therapeutics
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- How to Invest in Small Cap Stocks
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- The 3 Best Fintech Stocks to Buy Now
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
